Incidence trends of adult malignant brain tumors in Finland, 1990-2016
Natukka T, Raitanen J, Haapasalo H, Auvinen A. Incidence trends of adult malignant brain tumors in Finland, 1990-2016. Acta Oncol. 2019 Apr 15:1-7. doi: 10.1080/0284186X.2019.1603396.
Abstract
BACKGROUND: Several studies have reported increased incidence trends of malignant gliomas in the late 1900s with a plateau in the 2000s, but also some recent increases have been reported. The purpose of our study was to analyze incidence trends of malignant gliomas in Finland by morphology and tumor location.
MATERIAL AND METHODS: Data on 4730 malignant glioma patients were obtained from case notifications to the nationwide, population-based Finnish Cancer Registry (FCR), and less detailed data on 3590 patients up to 2016. Age-standardized incidence rates (ASR) and average annual percent changes (APCs) in the incidence rates were calculated by histological subtype and tumor location.
RESULTS: The incidence rate of gliomas was 7.7/100,000 in 1990-2006 and 7.3 in 2007-2016. The incidence of all gliomas combined was stable during both study periods, with no departure from linearity. In an analysis by age group, increasing incidence was found only for ages 80 years and older (1990-2006). During both study periods, incidence rates were increasing in glioblastoma and decreasing in unspecified brain tumors. In 1990-2006, rates were also increasing for anaplastic oligodendroglioma, oligoastrocytoma and unspecified malignant glioma, while decreasing for astrocytoma. As for tumor location, incidence in 1990-2006 was increasing for frontal lobe and brainstem tumors, as well as those with an unspecified location, but decreasing for the parietal lobes, cerebrum and ventricles.
CONCLUSIONS: No increasing incidence trend was observed for malignant gliomas overall. An increasing incidence trend of malignant gliomas was found in the oldest age group during 1990-2006.
Excerpts
The incidence trend of glioblastoma was slightly increasing (APC: +0.8%; 95% CI: 0.0, +1.7 for 1990–2006 and +1.9%; 95% CI: +0.2, +3.5 for 2007–2016; Tables 2 and
Incidence of glioblastoma increased slightly throughout the study period, while unspecified tumors of the brain showed a decreasing incidence trend.
We also found a slightly increasing incidence trend for the most common histological subtype, glioblastoma, which is consistent with several other studies [1,5,7–9,11,17,18]. A study from United States showed an increasing incidence trend for gliomas in the frontal lobe and decreasing trends for the cerebrum, ventricles and overlapping subtypes [17].
References
[1] Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol. 2017;19: v1–v88.
[1] Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol. 2017;19: v1–v88.
--
Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015
Keinan-Boker
L, Friedman E, Silverman BG. Trends in the incidence of primary brain,
central nervous system and intracranial tumors in Israel, 1990-2015.
Cancer Epidemiol. 2018 Oct;56:6-13. doi: 10.1016/j.canep.2018.07.003.
Highlights
• Exponential growth in cellphone use fueled concerns regarding brain and CNS tumors.
Abstract
BACKGROUND:
The association between cellphone technology and brain, central nervous
system (CNS) and intracranial tumors is unclear. Analysis of trends in
incidence of such tumors for periods during which cellphone use
increased dramatically may add relevant information. Herein we describe
secular trends in the incidence of primary tumors of the brain and CNS
from 1990 to 2015 in Israel, a period during which cellphone technology
became extremely prevalent in Israel.
METHODS:
All cases of primary brain, CNS and intracranial tumors (excluding
lymphomas) diagnosed in Israel from 1990 to 2015 were identified in the
Israel National Cancer Registry database and categorized by behavior
(malignant; benign/uncertain behavior) and histologic type. Annual
age-standardized incidence rates by sex and population group (Jews;
Arabs) were computed, and the annual percent changes and 95% confidence
intervals per category were calculated using Joinpoint software.
RESULTS:
Over 26 years (1990-2015) no significant changes in the incidence of
malignant brain, CNS and intracranial tumors were observed, except for
an increase in malignant glioma incidence in Jewish women up to 2008 and
Arab men up to 2001, which levelled off in both subgroups thereafter.
The incidence of benign/uncertain behavior brain, CNS and intracranial
tumors increased in most population groups up to the mid-2000s, a trend
mostly driven by changes in the incidence of meningioma, but either
significantly decreased (Jews) or stabilized (Arabs) thereafter.
CONCLUSIONS:
Our findings are not consistent with a discernable effect of cellphone
use patterns in Israel on incidence trends of brain, CNS and
intracranial tumors.
Excerpts
"When
cancer occurrence rates referred to glioblastomas only, Joinpoint
analysis of incidence trends was restricted to the period from 1995 to
2015 due to small numbers of cases in the Arab population prior to 1995.
Stable incidence trends were noted, with non-significant APCs, in all
population subgroups: APC1995–2015 for Jewish men was +0.6% (95%CI
-0.4%,+1.6%); APC1995–2015 for Jewish women was +0.6% (95%CI
-0.1%,+1.6%); APC1995–2015 for Arab men was -1.6% (95%CI -3.9%,+0.8%);
APC1995–2015 for Arab women was +0.4% (95%CI -2.9%,+3.8%).
Analysis
of time trends by age groups disclosed stable trends in most
population- age- and sex groups, except for a mild increase in Jewish
males aged 65 and over (APC1990–2015 +1.2%, p < 0.05) and in Arab
males aged 20–64 (APC1990–2015 +1.5%, p < 0.05). In the population of
Arab females, lack of cases in the age groups of 20–64 and 65+ in
certain years prevented an analysis of trends."
"However,
ecologic studies, of which ours is an example, may be insensitive to
excess in risk which is restricted to certain groups (for example, heavy
users or subjects exposed from very young ages) or to certain tumor
types (e.g., tumors that are very rare, that involve specific anatomical
sites, or that have unusually long latency periods) [34]. Little et al.
[35] also commented that the predicted rates of glioma based on data
derived from the small proportion of highly exposed people in the
Interphone study, could be consistent with the observed rates in their
study [35]. Therefore, although a substantial risk is not very
plausible, smaller risks cannot be ruled out and future research should
address specific exposure groups, and tumor types and sites, and should
allow for longer follow up periods."
--England: Brain Cancer Incidence Increased in Temporal and Frontal Lobes of Brain since 1995
A new study of cancer data in England essentially replicated the results of the Philips et al study (see below). The study found that the two age groups most vulnerable to carcinogenic effects from cell phone use -- young and elderly adults -- showed increased incidence over time in brain cancer in the frontal and temporal lobes of the brain -- the two lobes that receive the greatest dose of microwave radiation when cell phones are used near the head during phone calls.
However, Frank de Vocht, the author of this paper, rejected the explanation that cell phone use caused the increased cancer risk. He attributed the increased incidence to better diagnosis of brain tumors, especially in the elderly. Of course, this does not explain why the increase was only observed in the frontal and temporal lobes. He did not rule out the possibility that cell phone radiation may be a contributing factor to the observed increase.
Microwave News reported on this study and published the following graph obtained from Alasdair Philips (Microwave News, "Location, Location, Location: Aggressive Brain Tumors Tell a Story; GBM Rise Only in Frontal and Temporal Lobes, Oct 26, 2018.)
de Vocht F. Analyses of temporal and spatial patterns of Glioblastoma Multiforme and other brain cancers subtypes in relation to mobile phones using synthetic counterfactuals. Environmental Research. Available online 17 October 2018. https://doi.org/10.1016/j.
Highlights
• English 1985–2005 brain cancer subtype rates were compared to counterfactual trends
• Excess GBM increases were found in the frontal and temporal lobes, and cerebellum
• Mobile phone use was unlikely to have been an important putative factor
• No evidence of an effect of mobile phone use on acoustic neuroma and meningioma
Abstract
This study assesses whether temporal trends in glioblastoma multiforme (GBM) in different brain regions, and of different malignant and benign (including acoustic neuroma and meningioma) subtypes in the temporal lobe, could be associated with mobile phone use.
• English 1985–2005 brain cancer subtype rates were compared to counterfactual trends
• Excess GBM increases were found in the frontal and temporal lobes, and cerebellum
• Mobile phone use was unlikely to have been an important putative factor
• No evidence of an effect of mobile phone use on acoustic neuroma and meningioma
Abstract
This study assesses whether temporal trends in glioblastoma multiforme (GBM) in different brain regions, and of different malignant and benign (including acoustic neuroma and meningioma) subtypes in the temporal lobe, could be associated with mobile phone use.
Annual
1985–2005 incidence of brain cancer subtypes for England were linked to
population-level covariates. Bayesian structural timeseries were used
to create 2006–2014 counterfactual trends, and differences with measured
newly diagnosed cases were interpreted as causal effects.
Increases in excess of the counterfactuals for GBM were found in the temporal (+38% [95% Credible Interval -7%,78%]) and frontal (+36% [-8%,77%]) lobes, which were in agreement with hypothesised temporal and spatial mechanisms of mobile phone usage, and cerebellum (+59% [-0%,120%]). However, effects were primarily present in older age groups, with largest effects in 75+ and 85+ groups, indicating mobile phone use is unlikely to have been an important putative factor. There was no evidence of an effect of mobile phone use on incidence of acoustic neuroma and meningioma.
Although 1985–2014 trends in GBM in the temporal and frontal lobes, and probably cerebellum, seem consistent with mobile phone use as an important putative factor, age-group specific analyses indicate that it is unlikely that this correlation is causal.
Excerpts
Assessment of specific cancer subtypes in the temporal lobe indicated that the excess incidence was mainly found for GBM, with similar trends observed in the frontal lobe and cerebellum.... The increased rates of specific brain cancer subtypes in excess of the counterfactuals correspond to the spatial and temporal patterns that would be expected if exposure to RF from mobile phones were an important putative factor (Cardis et al., 2008, Morgan et al., 2016) ... However, age group-specific analyses indicate that the excess relative impacts increased with age over 65 years and were primarily found in the very old (75/85+ years of age) for whom it is unlikely that mobile phone use had been an important causal factor. In addition, excess numbers of newly diagnosed cases were also observed in the young (<24 years of age) for whom mobile phone use is also an unlikely causal factor....
The assumption that a 10-year lag was the most plausible period between first exposure and when increased risk could be observed in registry data was based on the previous analyses (De Vocht (2016)). Although sensitivity analysis using a 15-year lag showed no evidence of excesses relative to counterfactuals, this may still have been too short....
Increases in excess of the counterfactuals for GBM were found in the temporal (+38% [95% Credible Interval -7%,78%]) and frontal (+36% [-8%,77%]) lobes, which were in agreement with hypothesised temporal and spatial mechanisms of mobile phone usage, and cerebellum (+59% [-0%,120%]). However, effects were primarily present in older age groups, with largest effects in 75+ and 85+ groups, indicating mobile phone use is unlikely to have been an important putative factor. There was no evidence of an effect of mobile phone use on incidence of acoustic neuroma and meningioma.
Although 1985–2014 trends in GBM in the temporal and frontal lobes, and probably cerebellum, seem consistent with mobile phone use as an important putative factor, age-group specific analyses indicate that it is unlikely that this correlation is causal.
Excerpts
Assessment of specific cancer subtypes in the temporal lobe indicated that the excess incidence was mainly found for GBM, with similar trends observed in the frontal lobe and cerebellum.... The increased rates of specific brain cancer subtypes in excess of the counterfactuals correspond to the spatial and temporal patterns that would be expected if exposure to RF from mobile phones were an important putative factor (Cardis et al., 2008, Morgan et al., 2016) ... However, age group-specific analyses indicate that the excess relative impacts increased with age over 65 years and were primarily found in the very old (75/85+ years of age) for whom it is unlikely that mobile phone use had been an important causal factor. In addition, excess numbers of newly diagnosed cases were also observed in the young (<24 years of age) for whom mobile phone use is also an unlikely causal factor....
The assumption that a 10-year lag was the most plausible period between first exposure and when increased risk could be observed in registry data was based on the previous analyses (De Vocht (2016)). Although sensitivity analysis using a 15-year lag showed no evidence of excesses relative to counterfactuals, this may still have been too short....
This study, in agreement
with other data from the UK and elsewhere, shows that the incidence of
glioblastoma multiforme (astrocytoma grade IV) has increased
significantly since the 1980s, especially in the frontal and temporal
lobes and cerebellum. However, it further provides evidence that the
trend of increasing numbers of newly diagnosed cases of glioblastoma
multiforme in the temporal lobe (but likely in the frontal lobe and
cerebellum as well) since the mid-1980s, although seemingly consistent
with the hypothesis of exposure to radiofrequency radiation from mobile
phones being an important putative factor, should to a large extent (if
not exclusively) be attributed to another factor or factors; of which
improvements in diagnostic techniques, especially in the elderly, seems
the most plausible. Although these analyses indicate that it is unlikely
that exposure to RF from mobile phones is an important putative factor,
they also cannot exclude it as a contributing factor completely. It is
therefore important to keep monitoring incidence trend data.
Competing financial interests
declaration: The author has previously done consulting for EPRI
[Electric Power Research Institute], not related to this work.
Financial
support: No external funding was obtained for this study.
Mar 25, 2018
England: Rates of Aggressive
Brain Cancer Increased from 1995 to 2014
A newly-published study of brain tumor incidence trends in England
from 1995 to 2014 found that the trends over time varied by type of cancer,
especially in the frontal and temporal lobes.
The study found “a sustained and
highly statistically significant” increase in glioblastoma multiforme (GBM), the
most common brain cancer, across all ages. The rate of GBM more than doubled
from 2.4 to 5.0 per 100,000 people. However, this increase was mostly hidden
because the overall malignant brain tumor trend was relatively flat due to a
reduced incidence of lower grade brain tumors.
In England in 1995, when the tumor site was specified at the time of diagnosis, the frontal or temporal lobes of the
brain accounted for 41% of malignant brain tumors. By 2015, these two sites accounted for 60% of the tumors.
One cannot know from tumor registry data alone what
caused these differential trends in brain cancer. Based upon epidemiologic
research, the most compelling explanation for the increased incidence in these
deadly brain tumors, especially in the frontal and temporal lobes, may be
exposure to microwave radiation due to widespread adoption of cell phones. However,
the increased use of CT imaging scans is an alternative, but less compelling,
explanation because far fewer people would have been exposed to this form of
ionizing radiation.
In the U.S., Zada and his colleagues (2012) obtained similar results in an
analysis of national tumor registry data from 1992 to 2006.
Those who cite statistics which appear to show a
flat-line trend in overall brain
tumor incidence and argue that cell phone use doesn’t cause brain cancer need
to examine data on the location and type of brain tumors over time.
Also see:
Brain Tumor Rates Are Rising in the US: Role of Cellphone & Cordless Phone Use
The Incidence of Meningioma, a Non-Malignant Brain Tumor, is Increasing in the U.S.
The Incidence of Meningioma, a Non-Malignant Brain Tumor, is Increasing in the U.S.
Microwave News. “Aggressive Brain Tumors on the Rise in
England.” March 25, 2018. http://microwavenews.com/news-center/gbms-rising-uk
 |
| Source: Alasdair Philips via Microwave News. |
--
Brain tumours: rise in Glioblastoma
Multiforme incidence in England 1995–2015 suggests an adverse environmental or
lifestyle factor
Alasdair
Philips, Denis L. Henshaw, Graham Lamburn, and Michael O'Carroll. Brain
tumours: rise in Glioblastoma Multiforme incidence in England 1995–2015
suggests an adverse environmental or lifestyle factor. Journal of Environmental
and Public Health.
Highlights
• A clear description of the changing pattern in
incidence of brain tumour types
• The study used extensive data from an official and
recognised quality source
• The study included histological and morphological
information
• The study identified a significant and concerning
incidence time trend
• Some evidence is provided to help guide future research
into causal mechanisms
Abstract
Objective To investigate detailed trends in
malignant brain tumour incidence over a recent time period.
Methods UK Office of National Statistics (ONS)
data covering 81,135 ICD10 C71 brain tumours diagnosed in England (1995–2015)
were used to calculate incidence rates (ASR) per 100k person–years,
age–standardised to the European Standard Population (ESP–2013).
Results We report a sustained and highly
statistically significant ASR rise in glioblastoma multiforme (GBM) across all
ages. The ASR for GBM more than doubled from 2.4 to 5.0, with annual case
numbers rising from 983 to 2531. Overall, this rise is mostly hidden in the
overall data by a reduced incidence of lower grade tumours.
Conclusions The rise is of importance for clinical
resources and brain tumour aetiology. The rise cannot be fully accounted for by
promotion of lower–grade tumours, random chance or improvement in diagnostic
techniques as it affects specific areas of the brain and only one type of brain
tumour. Despite the large variation in case numbers by age, the percentage rise
is similar across the age groups which suggests widespread environmental or
lifestyle factors may be responsible.
1/. We show a linear, large and highly statistically
significant increase in primary GBM tumours over 21 years from 1995–2015, especially in frontal and temporal
lobes of the brain. This has aetiological and resource implications.
2/. Although most of the cases are in the group over 54
years of age, the age–standardised AAPC rise is strongly statistically significant in all our
three main analysis age groups.
3/. The rise in age–standardised incidence cannot be
fully accounted for by improved diagnosis as it affects specific areas of the
brain and just one type of brain tumour which is generally fatal. We suggest
that widespread environmental or lifestyle factors may be responsible.
4/. Our results highlight an urgent need for funding more
research into the initiation and promotion of GBM tumours. This should include
the use of CT imaging for diagnosis and also modern lifestyle factors that may
affect tumour metabolism.
